These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 26637732

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Current strategies in the diagnosis and management of chronic neutrophilic leukemia.
    Otgonbat A, Zhao M.
    Chin Med J (Engl); 2014; 127(24):4258-62. PubMed ID: 25533830
    [Abstract] [Full Text] [Related]

  • 24. Current and evolving understanding of atypical chronic myeloid leukemia.
    Schwartz LC, Mascarenhas J.
    Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
    [Abstract] [Full Text] [Related]

  • 25. [CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia].
    Cui Y, Li B, Jiang Q, Xu Z, Qin T, Zhang P, Zhang Y, Xiao Z.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1069-73. PubMed ID: 25543699
    [Abstract] [Full Text] [Related]

  • 26. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
    Fleischman AG, Maxson JE, Luty SB, Agarwal A, Royer LR, Abel ML, MacManiman JD, Loriaux MM, Druker BJ, Tyner JW.
    Blood; 2013 Nov 21; 122(22):3628-31. PubMed ID: 24081659
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature.
    Wang L, Du F, Zhang HM, Wang HX.
    Braz J Med Biol Res; 2015 Jul 21; 48(7):583-7. PubMed ID: 26017341
    [Abstract] [Full Text] [Related]

  • 29. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V, Ubezio M, Manes N, Milanesi C, Della Porta M, Bonometti A.
    Leuk Lymphoma; 2023 Sep 21; 64(9):1566-1573. PubMed ID: 37395413
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
    Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger S.
    Leukemia; 2013 Sep 21; 27(9):1852-60. PubMed ID: 23628959
    [Abstract] [Full Text] [Related]

  • 34. Research progress of additional pathogenic mutations in chronic neutrophilic leukemia.
    Gao J, Han S, Deng B, Deng Y, Gao X.
    Ann Hematol; 2024 Aug 21; 103(8):2591-2600. PubMed ID: 37993585
    [Abstract] [Full Text] [Related]

  • 35. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.
    Freedman JL, Desai AV, Bailey LC, Aplenc R, Burnworth B, Zehentner BK, Teachey DT, Wertheim G.
    Pediatr Blood Cancer; 2016 Jan 21; 63(1):156-9. PubMed ID: 26274939
    [Abstract] [Full Text] [Related]

  • 36. Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.
    Meggendorfer M, Haferlach T, Alpermann T, Jeromin S, Haferlach C, Kern W, Schnittger S.
    Haematologica; 2014 Dec 21; 99(12):e244-6. PubMed ID: 25239264
    [No Abstract] [Full Text] [Related]

  • 37. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications.
    Mitsumori T, Komatsu N, Kirito K.
    Intern Med; 2016 Dec 21; 55(4):405-7. PubMed ID: 26875968
    [Abstract] [Full Text] [Related]

  • 38. Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.
    Drexler HG, Nagel S, Quentmeier H.
    Curr Oncol; 2021 May 10; 28(3):1790-1794. PubMed ID: 34068566
    [Abstract] [Full Text] [Related]

  • 39. Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia.
    Dao KH, Solti MB, Maxson JE, Winton EF, Press RD, Druker BJ, Tyner JW.
    Leuk Res Rep; 2014 May 10; 3(2):67-9. PubMed ID: 25180155
    [Abstract] [Full Text] [Related]

  • 40. Genetic Response of Chronic Neutrophilic Leukemia With CSF3R T618I, SETBP1, and ASXL1 Mutations After Decitabine Therapy.
    Cao S, Tao Q, Wang J, Zhang Q, Dong Y.
    Am J Ther; 2014 May 10; 31(5):e550-e552. PubMed ID: 39292831
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.